In our study we advance another step, showing that the efficacy of ICI is greater in lung cancer models secreting G-CSF vs. those that do not (Figure 1 and Figure S2), suggesting that this improvement is mediated via neutrophils. The gene discussed is CSF3; the disease is lung carcinoma.